Open AccessP111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma
Author(s) -
Kambhampati Swetha,
Mei Matthew,
Chen Lu,
Puvurel Sandrine,
Chen Robert,
Popplewell Leslie,
Nikolaenko Liana,
Peters Lacolle,
Armenian Saro,
Kwak Larry,
Rosen Steven T.,
Forman Stephen,
Herrera Alex F.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000891012.42031.20
Subject(s) - brentuximab vedotin , medicine , refractory (planetary science) , gastroenterology , lymphoma , hodgkin lymphoma , pharmacology , biology , astrobiology